| 申込番号 |
更新日 |
ホモロジー | E-value | 鋳型 |
価格 |
アノテーション |
| SARAI_0001 |
2003/09/23 |
34%
(707-980) | e-112 | 3LCK |
*1 |
A24571#protein-tyrosine kinase (EC 2.7.1.112) erbB2 precursor - human |
| SARAI_0002 |
2003/09/23 |
33%
(711-1006) | e-111 | 1IRK |
*1 |
A24571#protein-tyrosine kinase (EC 2.7.1.112) erbB2 precursor - human |
| SARAI_0003 |
2003/09/23 |
23%
(717-918) | 5e-33 | 1B39_A |
*1 |
A24571#protein-tyrosine kinase (EC 2.7.1.112) erbB2 precursor - human |
| SARAI_0004 |
2003/09/23 |
23%
(717-918) | 5e-33 | 1B39_A |
*1 |
A24571#protein-tyrosine kinase (EC 2.7.1.112) erbB2 precursor - human with ligand |
| SARAI_0005 |
2003/09/23 |
25%
(726-917) | 2e-28 | 1ERK |
*1 |
A24571#protein-tyrosine kinase (EC 2.7.1.112) erbB2 precursor - human |
| SARAI_0006 |
2003/09/23 |
21%
(725-966) | 6e-23 | 1A06 |
*1 |
A24571#protein-tyrosine kinase (EC 2.7.1.112) erbB2 precursor - human |
| SARAI_0007 |
2003/09/23 |
25%
(712-937) | 2e-22 | 1WFC |
*1 |
A24571#protein-tyrosine kinase (EC 2.7.1.112) erbB2 precursor - human |
| SARAI_0008 |
2003/09/23 |
30%
(354-615) | 3e-66 | 1A06 |
*1 |
A39666#protein kinase C (EC 2.7.1.-) eta - human |
| SARAI_0009 |
2003/09/23 |
26%
(351-616) | 2e-48 | 1B39_A |
*1 |
A39666#protein kinase C (EC 2.7.1.-) eta - human |
| SARAI_0010 |
2003/09/23 |
26%
(351-616) | 2e-48 | 1B39_A |
*1 |
A39666#protein kinase C (EC 2.7.1.-) eta - human with ligand |
| SARAI_0011 |
2003/09/23 |
20%
(351-614) | 3e-34 | 1WFC |
*1 |
A39666#protein kinase C (EC 2.7.1.-) eta - human |
| SARAI_0012 |
2003/09/23 |
20%
(360-596) | 9e-34 | 1ERK |
*1 |
A39666#protein kinase C (EC 2.7.1.-) eta - human |
| SARAI_0013 |
2003/09/23 |
22%
(349-618) | 3e-24 | 1IRK |
*1 |
A39666#protein kinase C (EC 2.7.1.-) eta - human |
| SARAI_0014 |
2003/09/23 |
21%
(355-595) | 7e-24 | 3LCK |
*1 |
A39666#protein kinase C (EC 2.7.1.-) eta - human |
| SARAI_0015 |
2003/09/23 |
60%
(245-294) | 4e-21 | 1PTR |
*1 |
A39666#protein kinase C (EC 2.7.1.-) eta - human |
| SARAI_0016 |
2003/09/23 |
60%
(245-294) | 4e-21 | 1PTR |
*1 |
A39666#protein kinase C (EC 2.7.1.-) eta - human with ligand |
| SARAI_0017 |
2003/09/23 |
35%
(171-221) | 2e-15 | 1PTR |
*1 |
A39666#protein kinase C (EC 2.7.1.-) eta - human |
| SARAI_0018 |
2003/09/23 |
35%
(171-221) | 2e-15 | 1PTR |
*1 |
A39666#protein kinase C (EC 2.7.1.-) eta - human with ligand |
| SARAI_0019 |
2003/09/23 |
28%
(65-363) | 1e-82 | 1B39_A |
*1 |
A45100#mitogen-activated protein kinase kinase (EC 2.7.1.-) 1, splice form A [validated] - human |
| SARAI_0020 |
2003/09/23 |
28%
(65-363) | 1e-82 | 1B39_A |
*1 |
A45100#mitogen-activated protein kinase kinase (EC 2.7.1.-) 1, splice form A [validated] - human with ligand |
| SARAI_0021 |
2003/09/23 |
22%
(68-364) | 2e-56 | 1ERK |
*1 |
A45100#mitogen-activated protein kinase kinase (EC 2.7.1.-) 1, splice form A [validated] - human |
| SARAI_0022 |
2003/09/23 |
22%
(50-368) | 5e-56 | 1WFC |
*1 |
A45100#mitogen-activated protein kinase kinase (EC 2.7.1.-) 1, splice form A [validated] - human |
| SARAI_0023 |
2003/09/23 |
20%
(66-371) | 1e-55 | 1A06 |
*1 |
A45100#mitogen-activated protein kinase kinase (EC 2.7.1.-) 1, splice form A [validated] - human |
| SARAI_0024 |
2003/09/23 |
21%
(58-306) | 1e-38 | 3LCK |
*1 |
A45100#mitogen-activated protein kinase kinase (EC 2.7.1.-) 1, splice form A [validated] - human |
| SARAI_0025 |
2003/09/23 |
20%
(59-330) | 5e-35 | 1IRK |
*1 |
A45100#mitogen-activated protein kinase kinase (EC 2.7.1.-) 1, splice form A [validated] - human |
| SARAI_0026 |
2003/09/23 |
29%
(380-636) | 6e-63 | 1A06 |
*1 |
A45416#protein kinase C (EC 2.7.1.-) theta - human |
| SARAI_0027 |
2003/09/23 |
26%
(377-637) | 7e-51 | 1B39_A |
*1 |
A45416#protein kinase C (EC 2.7.1.-) theta - human |
| SARAI_0028 |
2003/09/23 |
26%
(377-637) | 7e-51 | 1B39_A |
*1 |
A45416#protein kinase C (EC 2.7.1.-) theta - human with ligand |
| SARAI_0029 |
2003/09/23 |
24%
(377-635) | 2e-36 | 1WFC |
*1 |
A45416#protein kinase C (EC 2.7.1.-) theta - human |
| SARAI_0030 |
2003/09/23 |
23%
(386-633) | 3e-33 | 1ERK |
*1 |
A45416#protein kinase C (EC 2.7.1.-) theta - human |
| SARAI_0031 |
2003/09/23 |
23%
(375-646) | 2e-26 | 1IRK |
*1 |
A45416#protein kinase C (EC 2.7.1.-) theta - human |
| SARAI_0032 |
2003/09/23 |
24%
(381-621) | 2e-25 | 3LCK |
*1 |
A45416#protein kinase C (EC 2.7.1.-) theta - human |
| SARAI_0033 |
2003/09/23 |
80%
(232-281) | 5e-24 | 1PTR |
*1 |
A45416#protein kinase C (EC 2.7.1.-) theta - human |
| SARAI_0034 |
2003/09/23 |
80%
(232-281) | 5e-24 | 1PTR |
*1 |
A45416#protein kinase C (EC 2.7.1.-) theta - human with ligand |
| SARAI_0035 |
2003/09/23 |
42%
(160-209) | 2e-15 | 1PTR |
*1 |
A45416#protein kinase C (EC 2.7.1.-) theta - human |
| SARAI_0036 |
2003/09/23 |
42%
(160-209) | 2e-15 | 1PTR |
*1 |
A45416#protein kinase C (EC 2.7.1.-) theta - human with ligand |
| SARAI_0037 |
2003/09/23 |
25%
(245-515) | 1e-60 | 1A06 |
*1 |
A49509#protein kinase C (EC 2.7.1.-) iota - human |
| SARAI_0038 |
2003/09/23 |
25%
(242-516) | 4e-47 | 1B39_A |
*1 |
A49509#protein kinase C (EC 2.7.1.-) iota - human |
| SARAI_0039 |
2003/09/23 |
25%
(242-516) | 4e-47 | 1B39_A |
*1 |
A49509#protein kinase C (EC 2.7.1.-) iota - human with ligand |
| SARAI_0040 |
2003/09/23 |
20%
(251-496) | 3e-35 | 1ERK |
*1 |
A49509#protein kinase C (EC 2.7.1.-) iota - human |
| SARAI_0041 |
2003/09/23 |
21%
(242-514) | 8e-35 | 1WFC |
*1 |
A49509#protein kinase C (EC 2.7.1.-) iota - human |
| SARAI_0042 |
2003/09/23 |
19%
(240-518) | 2e-25 | 1IRK |
*1 |
A49509#protein kinase C (EC 2.7.1.-) iota - human |
| SARAI_0043 |
2003/09/23 |
20%
(246-495) | 5e-25 | 3LCK |
*1 |
A49509#protein kinase C (EC 2.7.1.-) iota - human |
| SARAI_0044 |
2003/09/23 |
36%
(132-181) | 3e-22 | 1PTR |
*1 |
A49509#protein kinase C (EC 2.7.1.-) iota - human |
| SARAI_0045 |
2003/09/23 |
36%
(132-181) | 3e-22 | 1PTR |
*1 |
A49509#protein kinase C (EC 2.7.1.-) iota - human with ligand |
| SARAI_0046 |
2003/09/23 |
17%
(23-212) | 7e-06 | 1KI8_B |
*1 |
A55122#deoxycytidine kinase (EC 2.7.1.74) - mouse |
| SARAI_0047 |
2003/09/23 |
17%
(23-212) | 7e-06 | 1KI8_B |
*1 |
A55122#deoxycytidine kinase (EC 2.7.1.74) - mouse with ligand |
| SARAI_0048 |
2003/09/23 |
17%
(23-212) | 2e-05 | 1KI8_A |
*1 |
A55122#deoxycytidine kinase (EC 2.7.1.74) - mouse |
| SARAI_0049 |
2003/09/23 |
17%
(23-212) | 2e-05 | 1KI8_A |
*1 |
A55122#deoxycytidine kinase (EC 2.7.1.74) - mouse with ligand |
| SARAI_0050 |
2003/09/23 |
30%
(171-193) | 5e-04 | 3ADK |
*1 |
A55122#deoxycytidine kinase (EC 2.7.1.74) - mouse |
| SARAI_0051 |
2003/09/23 |
30%
(30-323) | e-103 | 1B39_A |
*1 |
B30319#casein kinase II (EC 2.7.1.-) alpha chain - rat (fragment) |
| SARAI_0052 |
2003/09/23 |
30%
(30-323) | e-103 | 1B39_A |
*1 |
B30319#casein kinase II (EC 2.7.1.-) alpha chain - rat (fragment) with ligand |
| SARAI_0053 |
2003/09/23 |
29%
(31-316) | 2e-94 | 1ERK |
*1 |
B30319#casein kinase II (EC 2.7.1.-) alpha chain - rat (fragment) |
| SARAI_0054 |
2003/09/23 |
27%
(16-323) | 1e-91 | 1WFC |
*1 |
B30319#casein kinase II (EC 2.7.1.-) alpha chain - rat (fragment) |
| SARAI_0055 |
2003/09/23 |
23%
(29-316) | 1e-34 | 1A06 |
*1 |
B30319#casein kinase II (EC 2.7.1.-) alpha chain - rat (fragment) |
| SARAI_0056 |
2003/09/23 |
20%
(25-228) | 8e-26 | 3LCK |
*1 |
B30319#casein kinase II (EC 2.7.1.-) alpha chain - rat (fragment) |
| SARAI_0057 |
2003/09/23 |
21%
(25-218) | 3e-23 | 1IRK |
*1 |
B30319#casein kinase II (EC 2.7.1.-) alpha chain - rat (fragment) |
| SARAI_0058 |
2003/09/23 |
28%
(351-616) | 3e-64 | 1A06 |
*1 |
D24664#protein kinase C (EC 2.7.1.-) gamma - human |
| SARAI_0059 |
2003/09/23 |
66%
(156-288) | 5e-56 | 1A25_B |
*1 |
D24664#protein kinase C (EC 2.7.1.-) gamma - human |
| SARAI_0060 |
2003/09/23 |
66%
(156-288) | 5e-56 | 1A25_B |
*1 |
D24664#protein kinase C (EC 2.7.1.-) gamma - human with ligand |
| SARAI_0061 |
2003/09/23 |
66%
(156-288) | 5e-56 | 1A25_A |
*1 |
D24664#protein kinase C (EC 2.7.1.-) gamma - human |
| SARAI_0062 |
2003/09/23 |
22%
(348-617) | 6e-45 | 1B39_A |
*1 |
D24664#protein kinase C (EC 2.7.1.-) gamma - human |
| SARAI_0063 |
2003/09/23 |
22%
(348-617) | 6e-45 | 1B39_A |
*1 |
D24664#protein kinase C (EC 2.7.1.-) gamma - human with ligand |
| SARAI_0064 |
2003/09/23 |
22%
(357-598) | 4e-33 | 1ERK |
*1 |
D24664#protein kinase C (EC 2.7.1.-) gamma - human |
| SARAI_0065 |
2003/09/23 |
22%
(354-615) | 1e-32 | 1WFC |
*1 |
D24664#protein kinase C (EC 2.7.1.-) gamma - human |
| SARAI_0066 |
2003/09/23 |
25%
(352-597) | 5e-25 | 3LCK |
*1 |
D24664#protein kinase C (EC 2.7.1.-) gamma - human |
| SARAI_0067 |
2003/09/23 |
22%
(346-597) | 5e-24 | 1IRK |
*1 |
D24664#protein kinase C (EC 2.7.1.-) gamma - human |
| SARAI_0068 |
2003/09/23 |
62%
(101-150) | 2e-23 | 1PTR |
*1 |
D24664#protein kinase C (EC 2.7.1.-) gamma - human |
| SARAI_0069 |
2003/09/23 |
62%
(101-150) | 2e-23 | 1PTR |
*1 |
D24664#protein kinase C (EC 2.7.1.-) gamma - human with ligand |
| SARAI_0070 |
2003/09/23 |
44%
(36-85) | 5e-16 | 1PTR |
*1 |
D24664#protein kinase C (EC 2.7.1.-) gamma - human |
| SARAI_0071 |
2003/09/23 |
44%
(36-85) | 5e-16 | 1PTR |
*1 |
D24664#protein kinase C (EC 2.7.1.-) gamma - human with ligand |
| SARAI_0072 |
2003/09/23 |
47%
(354-621) | e-126 | 3LCK |
*1 |
FOMVGM#gag-abl polyprotein - Abelson murine leukemia virus |
| SARAI_0073 |
2003/09/23 |
39%
(354-616) | e-114 | 1IRK |
*1 |
FOMVGM#gag-abl polyprotein - Abelson murine leukemia virus |
| SARAI_0074 |
2003/09/23 |
65%
(174-339) | 5e-47 | 2ABL |
*1 |
FOMVGM#gag-abl polyprotein - Abelson murine leukemia virus |
| SARAI_0075 |
2003/09/23 |
36%
(242-339) | 2e-38 | 1A07_A |
*1 |
FOMVGM#gag-abl polyprotein - Abelson murine leukemia virus |
| SARAI_0076 |
2003/09/23 |
36%
(242-339) | 2e-38 | 1A07_A |
*1 |
FOMVGM#gag-abl polyprotein - Abelson murine leukemia virus with ligand |
| SARAI_0077 |
2003/09/23 |
35%
(243-339) | 6e-38 | 1A07_B |
*1 |
FOMVGM#gag-abl polyprotein - Abelson murine leukemia virus |
| SARAI_0078 |
2003/09/23 |
35%
(243-339) | 6e-38 | 1A07_B |
*1 |
FOMVGM#gag-abl polyprotein - Abelson murine leukemia virus with ligand |
| SARAI_0079 |
2003/09/23 |
35%
(246-340) | 8e-37 | 1SKJ |
*1 |
FOMVGM#gag-abl polyprotein - Abelson murine leukemia virus |
| SARAI_0080 |
2003/09/23 |
35%
(246-340) | 8e-37 | 1SKJ |
*1 |
FOMVGM#gag-abl polyprotein - Abelson murine leukemia virus with ligand |
| SARAI_0081 |
2003/09/23 |
25%
(361-589) | 2e-36 | 1B39_A |
*1 |
FOMVGM#gag-abl polyprotein - Abelson murine leukemia virus |
| SARAI_0082 |
2003/09/23 |
25%
(361-589) | 2e-36 | 1B39_A |
*1 |
FOMVGM#gag-abl polyprotein - Abelson murine leukemia virus with ligand |
| SARAI_0083 |
2003/09/23 |
25%
(369-555) | 1e-31 | 1ERK |
*1 |
FOMVGM#gag-abl polyprotein - Abelson murine leukemia virus |
| SARAI_0084 |
2003/09/23 |
23%
(365-604) | 1e-30 | 1A06 |
*1 |
FOMVGM#gag-abl polyprotein - Abelson murine leukemia virus |
| SARAI_0085 |
2003/09/23 |
25%
(343-575) | 3e-28 | 1WFC |
*1 |
FOMVGM#gag-abl polyprotein - Abelson murine leukemia virus |
| SARAI_0086 |
2003/09/23 |
72%
(5-359) | e-145 | 1WFC |
*1 |
G02524#MAP kinase (EC 2.7.1.-) p38 beta - human |
| SARAI_0087 |
2003/09/23 |
44%
(13-358) | e-136 | 1ERK |
*1 |
G02524#MAP kinase (EC 2.7.1.-) p38 beta - human |
| SARAI_0088 |
2003/09/23 |
35%
(22-322) | e-123 | 1B39_A |
*1 |
G02524#MAP kinase (EC 2.7.1.-) p38 beta - human |
| SARAI_0089 |
2003/09/23 |
35%
(22-322) | e-123 | 1B39_A |
*1 |
G02524#MAP kinase (EC 2.7.1.-) p38 beta - human with ligand |
| SARAI_0090 |
2003/09/23 |
22%
(19-315) | 2e-38 | 1A06 |
*1 |
G02524#MAP kinase (EC 2.7.1.-) p38 beta - human |
| SARAI_0091 |
2003/09/23 |
28%
(18-233) | 5e-29 | 3LCK |
*1 |
G02524#MAP kinase (EC 2.7.1.-) p38 beta - human |
| SARAI_0092 |
2003/09/23 |
20%
(18-306) | 1e-27 | 1IRK |
*1 |
G02524#MAP kinase (EC 2.7.1.-) p38 beta - human |
| SARAI_0093 |
2003/09/23 |
32%
(699-971) | e-109 | 3LCK |
*1 |
GQHUE#epidermal growth factor receptor precursor - human |
| SARAI_0094 |
2003/09/23 |
30%
(701-988) | e-108 | 1IRK |
*1 |
GQHUE#epidermal growth factor receptor precursor - human |
| SARAI_0095 |
2003/09/23 |
25%
(711-909) | 7e-33 | 1B39_A |
*1 |
GQHUE#epidermal growth factor receptor precursor - human |
| SARAI_0096 |
2003/09/23 |
25%
(711-909) | 7e-33 | 1B39_A |
*1 |
GQHUE#epidermal growth factor receptor precursor - human with ligand |
| SARAI_0097 |
2003/09/23 |
23%
(718-909) | 2e-26 | 1ERK |
*1 |
GQHUE#epidermal growth factor receptor precursor - human |
| SARAI_0098 |
2003/09/23 |
22%
(717-958) | 4e-23 | 1A06 |
*1 |
GQHUE#epidermal growth factor receptor precursor - human |
| SARAI_0099 |
2003/09/23 |
26%
(717-927) | 2e-22 | 1WFC |
*1 |
GQHUE#epidermal growth factor receptor precursor - human |
| SARAI_0100 |
2003/09/23 |
61%
(8-354) | e-142 | 1WFC |
*1 |
JC5252#mitogen-activated protein kinase (EC 2.7.1.-) p38 gamma - human |
| SARAI_0101 |
2003/09/23 |
40%
(16-355) | e-135 | 1ERK |
*1 |
JC5252#mitogen-activated protein kinase (EC 2.7.1.-) p38 gamma - human |
| SARAI_0102 |
2003/09/23 |
35%
(27-317) | e-120 | 1B39_A |
*1 |
JC5252#mitogen-activated protein kinase (EC 2.7.1.-) p38 gamma - human |
| SARAI_0103 |
2003/09/23 |
35%
(27-317) | e-120 | 1B39_A |
*1 |
JC5252#mitogen-activated protein kinase (EC 2.7.1.-) p38 gamma - human with ligand |
| SARAI_0104 |
2003/09/23 |
25%
(17-310) | 1e-40 | 1A06 |
*1 |
JC5252#mitogen-activated protein kinase (EC 2.7.1.-) p38 gamma - human |
| SARAI_0105 |
2003/09/23 |
27%
(21-228) | 3e-29 | 3LCK |
*1 |
JC5252#mitogen-activated protein kinase (EC 2.7.1.-) p38 gamma - human |
| SARAI_0106 |
2003/09/23 |
21%
(21-311) | 4e-25 | 1IRK |
*1 |
JC5252#mitogen-activated protein kinase (EC 2.7.1.-) p38 gamma - human |
| SARAI_0107 |
2003/09/23 |
49%
(10-363) | e-130 | 1WFC |
*1 |
JC5531#c-Jun amino-terminal kinase (EC 2.7.1.-) 2 alpha1 - chicken |
| SARAI_0108 |
2003/09/23 |
38%
(14-369) | e-127 | 1ERK |
*1 |
JC5531#c-Jun amino-terminal kinase (EC 2.7.1.-) 2 alpha1 - chicken |
| SARAI_0109 |
2003/09/23 |
33%
(23-327) | e-114 | 1B39_A |
*1 |
JC5531#c-Jun amino-terminal kinase (EC 2.7.1.-) 2 alpha1 - chicken |
| SARAI_0110 |
2003/09/23 |
33%
(23-327) | e-114 | 1B39_A |
*1 |
JC5531#c-Jun amino-terminal kinase (EC 2.7.1.-) 2 alpha1 - chicken with ligand |
| SARAI_0111 |
2003/09/23 |
22%
(21-322) | 2e-41 | 1A06 |
*1 |
JC5531#c-Jun amino-terminal kinase (EC 2.7.1.-) 2 alpha1 - chicken |
| SARAI_0112 |
2003/09/23 |
25%
(20-227) | 4e-28 | 3LCK |
*1 |
JC5531#c-Jun amino-terminal kinase (EC 2.7.1.-) 2 alpha1 - chicken |
| SARAI_0113 |
2003/09/23 |
18%
(20-338) | 1e-24 | 1IRK |
*1 |
JC5531#c-Jun amino-terminal kinase (EC 2.7.1.-) 2 alpha1 - chicken |
| SARAI_0114 |
2003/09/23 |
34%
(719-1019) | e-110 | 1A06 |
*1 |
JN0583#myosin-light-chain kinase (EC 2.7.1.117) 155K protein - bovine |
| SARAI_0115 |
2003/09/23 |
22%
(723-992) | 7e-59 | 1B39_A |
*1 |
JN0583#myosin-light-chain kinase (EC 2.7.1.117) 155K protein - bovine |
| SARAI_0116 |
2003/09/23 |
22%
(723-992) | 7e-59 | 1B39_A |
*1 |
JN0583#myosin-light-chain kinase (EC 2.7.1.117) 155K protein - bovine with ligand |
| SARAI_0117 |
2003/09/23 |
20%
(720-998) | 1e-51 | 1ERK |
*1 |
JN0583#myosin-light-chain kinase (EC 2.7.1.117) 155K protein - bovine |
| SARAI_0118 |
2003/09/23 |
22%
(720-986) | 3e-49 | 1WFC |
*1 |
JN0583#myosin-light-chain kinase (EC 2.7.1.117) 155K protein - bovine |
| SARAI_0119 |
2003/09/23 |
86%
(1060-1162) | 9e-45 | 1TLK |
*1 |
JN0583#myosin-light-chain kinase (EC 2.7.1.117) 155K protein - bovine |
| SARAI_0120 |
2003/09/23 |
25%
(727-970) | 2e-35 | 3LCK |
*1 |
JN0583#myosin-light-chain kinase (EC 2.7.1.117) 155K protein - bovine |
| SARAI_0121 |
2003/09/23 |
21%
(722-976) | 8e-30 | 1IRK |
*1 |
JN0583#myosin-light-chain kinase (EC 2.7.1.117) 155K protein - bovine |
| SARAI_0122 |
2003/09/23 |
25%
(345-447) | 2e-26 | 1TLK |
*1 |
JN0583#myosin-light-chain kinase (EC 2.7.1.117) 155K protein - bovine |
| SARAI_0123 |
2003/09/23 |
23%
(492-590) | 5e-14 | 1TLK |
*1 |
JN0583#myosin-light-chain kinase (EC 2.7.1.117) 155K protein - bovine |
| SARAI_0124 |
2003/09/23 |
25%
(252-520) | 1e-61 | 1A06 |
*1 |
JN0877#protein kinase C (EC 2.7.1.-) zeta - human |
| SARAI_0125 |
2003/09/23 |
23%
(249-521) | 3e-48 | 1B39_A |
*1 |
JN0877#protein kinase C (EC 2.7.1.-) zeta - human |
| SARAI_0126 |
2003/09/23 |
23%
(249-521) | 3e-48 | 1B39_A |
*1 |
JN0877#protein kinase C (EC 2.7.1.-) zeta - human with ligand |
| SARAI_0127 |
2003/09/23 |
20%
(258-501) | 2e-35 | 1ERK |
*1 |
JN0877#protein kinase C (EC 2.7.1.-) zeta - human |
| SARAI_0128 |
2003/09/23 |
20%
(250-519) | 8e-35 | 1WFC |
*1 |
JN0877#protein kinase C (EC 2.7.1.-) zeta - human |
| SARAI_0129 |
2003/09/23 |
20%
(253-500) | 4e-26 | 3LCK |
*1 |
JN0877#protein kinase C (EC 2.7.1.-) zeta - human |
| SARAI_0130 |
2003/09/23 |
18%
(254-523) | 2e-25 | 1IRK |
*1 |
JN0877#protein kinase C (EC 2.7.1.-) zeta - human |
| SARAI_0131 |
2003/09/23 |
32%
(131-180) | 1e-22 | 1PTR |
*1 |
JN0877#protein kinase C (EC 2.7.1.-) zeta - human |
| SARAI_0132 |
2003/09/23 |
32%
(131-180) | 1e-22 | 1PTR |
*1 |
JN0877#protein kinase C (EC 2.7.1.-) zeta - human with ligand |
| SARAI_0133 |
2003/09/23 |
76%
(46-373) | e-125 | 1KI8_B |
*1 |
KIBET3#thymidine kinase (EC 2.7.1.21) - human herpesvirus 2 (strain 333) |
| SARAI_0134 |
2003/09/23 |
76%
(46-373) | e-125 | 1KI8_B |
*1 |
KIBET3#thymidine kinase (EC 2.7.1.21) - human herpesvirus 2 (strain 333) with ligand |
| SARAI_0135 |
2003/09/23 |
74%
(46-373) | e-123 | 1KI8_A |
*1 |
KIBET3#thymidine kinase (EC 2.7.1.21) - human herpesvirus 2 (strain 333) |
| SARAI_0136 |
2003/09/23 |
74%
(46-373) | e-123 | 1KI8_A |
*1 |
KIBET3#thymidine kinase (EC 2.7.1.21) - human herpesvirus 2 (strain 333) with ligand |
| SARAI_0137 |
2003/09/23 |
29%
(342-602) | 1e-67 | 1A06 |
*1 |
KIHUC1#protein kinase C (EC 2.7.1.-) beta-I - human |
| SARAI_0138 |
2003/09/23 |
97%
(157-288) | 6e-61 | 1A25_B |
*1 |
KIHUC1#protein kinase C (EC 2.7.1.-) beta-I - human |
| SARAI_0139 |
2003/09/23 |
97%
(157-288) | 6e-61 | 1A25_B |
*1 |
KIHUC1#protein kinase C (EC 2.7.1.-) beta-I - human with ligand |
| SARAI_0140 |
2003/09/23 |
97%
(157-288) | 6e-61 | 1A25_A |
*1 |
KIHUC1#protein kinase C (EC 2.7.1.-) beta-I - human |
| SARAI_0141 |
2003/09/23 |
23%
(339-603) | 6e-47 | 1B39_A |
*1 |
KIHUC1#protein kinase C (EC 2.7.1.-) beta-I - human |
| SARAI_0142 |
2003/09/23 |
23%
(339-603) | 6e-47 | 1B39_A |
*1 |
KIHUC1#protein kinase C (EC 2.7.1.-) beta-I - human with ligand |
| SARAI_0143 |
2003/09/23 |
23%
(339-601) | 2e-36 | 1WFC |
*1 |
KIHUC1#protein kinase C (EC 2.7.1.-) beta-I - human |
| SARAI_0144 |
2003/09/23 |
20%
(348-584) | 5e-34 | 1ERK |
*1 |
KIHUC1#protein kinase C (EC 2.7.1.-) beta-I - human |
| SARAI_0145 |
2003/09/23 |
26%
(348-583) | 9e-25 | 3LCK |
*1 |
KIHUC1#protein kinase C (EC 2.7.1.-) beta-I - human |
| SARAI_0146 |
2003/09/23 |
23%
(344-583) | 1e-23 | 1IRK |
*1 |
KIHUC1#protein kinase C (EC 2.7.1.-) beta-I - human |
| SARAI_0147 |
2003/09/23 |
62%
(102-151) | 2e-23 | 1PTR |
*1 |
KIHUC1#protein kinase C (EC 2.7.1.-) beta-I - human |
| SARAI_0148 |
2003/09/23 |
62%
(102-151) | 2e-23 | 1PTR |
*1 |
KIHUC1#protein kinase C (EC 2.7.1.-) beta-I - human with ligand |
| SARAI_0149 |
2003/09/23 |
42%
(37-86) | 1e-16 | 1PTR |
*1 |
KIHUC1#protein kinase C (EC 2.7.1.-) beta-I - human |
| SARAI_0150 |
2003/09/23 |
42%
(37-86) | 1e-16 | 1PTR |
*1 |
KIHUC1#protein kinase C (EC 2.7.1.-) beta-I - human with ligand |
| SARAI_0151 |
2003/09/23 |
29%
(342-602) | 3e-68 | 1A06 |
*1 |
KIHUC2#protein kinase C (EC 2.7.1.-) beta-II - human |
| SARAI_0152 |
2003/09/23 |
97%
(157-288) | 1e-60 | 1A25_B |
*1 |
KIHUC2#protein kinase C (EC 2.7.1.-) beta-II - human |
| SARAI_0153 |
2003/09/23 |
97%
(157-288) | 1e-60 | 1A25_B |
*1 |
KIHUC2#protein kinase C (EC 2.7.1.-) beta-II - human with ligand |
| SARAI_0154 |
2003/09/23 |
97%
(157-288) | 1e-60 | 1A25_A |
*1 |
KIHUC2#protein kinase C (EC 2.7.1.-) beta-II - human |
| SARAI_0155 |
2003/09/23 |
24%
(339-603) | 2e-47 | 1B39_A |
*1 |
KIHUC2#protein kinase C (EC 2.7.1.-) beta-II - human |
| SARAI_0156 |
2003/09/23 |
24%
(339-603) | 2e-47 | 1B39_A |
*1 |
KIHUC2#protein kinase C (EC 2.7.1.-) beta-II - human with ligand |
| SARAI_0157 |
2003/09/23 |
23%
(339-601) | 1e-36 | 1WFC |
*1 |
KIHUC2#protein kinase C (EC 2.7.1.-) beta-II - human |
| SARAI_0158 |
2003/09/23 |
20%
(348-584) | 8e-34 | 1ERK |
*1 |
KIHUC2#protein kinase C (EC 2.7.1.-) beta-II - human |
| SARAI_0159 |
2003/09/23 |
26%
(348-583) | 3e-24 | 3LCK |
*1 |
KIHUC2#protein kinase C (EC 2.7.1.-) beta-II - human |
| SARAI_0160 |
2003/09/23 |
62%
(102-151) | 2e-23 | 1PTR |
*1 |
KIHUC2#protein kinase C (EC 2.7.1.-) beta-II - human |
| SARAI_0161 |
2003/09/23 |
62%
(102-151) | 2e-23 | 1PTR |
*1 |
KIHUC2#protein kinase C (EC 2.7.1.-) beta-II - human with ligand |
| SARAI_0162 |
2003/09/23 |
23%
(344-583) | 3e-23 | 1IRK |
*1 |
KIHUC2#protein kinase C (EC 2.7.1.-) beta-II - human |
| SARAI_0163 |
2003/09/23 |
42%
(37-86) | 1e-16 | 1PTR |
*1 |
KIHUC2#protein kinase C (EC 2.7.1.-) beta-II - human |
| SARAI_0164 |
2003/09/23 |
42%
(37-86) | 1e-16 | 1PTR |
*1 |
KIHUC2#protein kinase C (EC 2.7.1.-) beta-II - human with ligand |
| SARAI_0165 |
2003/09/23 |
30%
(339-599) | 2e-69 | 1A06 |
*1 |
KIHUCA#protein kinase C (EC 2.7.1.-) alpha - human |
| SARAI_0166 |
2003/09/23 |
76%
(157-288) | 9e-58 | 1A25_B |
*1 |
KIHUCA#protein kinase C (EC 2.7.1.-) alpha - human |
| SARAI_0167 |
2003/09/23 |
76%
(157-288) | 9e-58 | 1A25_B |
*1 |
KIHUCA#protein kinase C (EC 2.7.1.-) alpha - human with ligand |
| SARAI_0168 |
2003/09/23 |
76%
(157-288) | 9e-58 | 1A25_A |
*1 |
KIHUCA#protein kinase C (EC 2.7.1.-) alpha - human |
| SARAI_0169 |
2003/09/23 |
25%
(336-600) | 2e-47 | 1B39_A |
*1 |
KIHUCA#protein kinase C (EC 2.7.1.-) alpha - human |
| SARAI_0170 |
2003/09/23 |
25%
(336-600) | 2e-47 | 1B39_A |
*1 |
KIHUCA#protein kinase C (EC 2.7.1.-) alpha - human with ligand |
| SARAI_0171 |
2003/09/23 |
23%
(336-598) | 2e-36 | 1WFC |
*1 |
KIHUCA#protein kinase C (EC 2.7.1.-) alpha - human |
| SARAI_0172 |
2003/09/23 |
20%
(345-581) | 4e-34 | 1ERK |
*1 |
KIHUCA#protein kinase C (EC 2.7.1.-) alpha - human |
| SARAI_0173 |
2003/09/23 |
25%
(340-580) | 1e-25 | 3LCK |
*1 |
KIHUCA#protein kinase C (EC 2.7.1.-) alpha - human |
| SARAI_0174 |
2003/09/23 |
21%
(334-580) | 2e-23 | 1IRK |
*1 |
KIHUCA#protein kinase C (EC 2.7.1.-) alpha - human |
| SARAI_0175 |
2003/09/23 |
62%
(102-151) | 4e-23 | 1PTR |
*1 |
KIHUCA#protein kinase C (EC 2.7.1.-) alpha - human |
| SARAI_0176 |
2003/09/23 |
62%
(102-151) | 4e-23 | 1PTR |
*1 |
KIHUCA#protein kinase C (EC 2.7.1.-) alpha - human with ligand |
| SARAI_0177 |
2003/09/23 |
42%
(37-86) | 7e-16 | 1PTR |
*1 |
KIHUCA#protein kinase C (EC 2.7.1.-) alpha - human |
| SARAI_0178 |
2003/09/23 |
42%
(37-86) | 7e-16 | 1PTR |
*1 |
KIHUCA#protein kinase C (EC 2.7.1.-) alpha - human with ligand |
| SARAI_0179 |
2003/09/23 |
30%
(339-599) | 2e-69 | 1A06 |
*1 |
KIRTC#protein kinase C (EC 2.7.1.-) alpha - rat |
| SARAI_0180 |
2003/09/23 |
76%
(157-288) | 3e-57 | 1A25_B |
*1 |
KIRTC#protein kinase C (EC 2.7.1.-) alpha - rat |
| SARAI_0181 |
2003/09/23 |
76%
(157-288) | 3e-57 | 1A25_B |
*1 |
KIRTC#protein kinase C (EC 2.7.1.-) alpha - rat with ligand |
| SARAI_0182 |
2003/09/23 |
76%
(157-288) | 3e-57 | 1A25_A |
*1 |
KIRTC#protein kinase C (EC 2.7.1.-) alpha - rat |
| SARAI_0183 |
2003/09/23 |
25%
(336-600) | 1e-47 | 1B39_A |
*1 |
KIRTC#protein kinase C (EC 2.7.1.-) alpha - rat |
| SARAI_0184 |
2003/09/23 |
25%
(336-600) | 1e-47 | 1B39_A |
*1 |
KIRTC#protein kinase C (EC 2.7.1.-) alpha - rat with ligand |
| SARAI_0185 |
2003/09/23 |
23%
(336-598) | 2e-36 | 1WFC |
*1 |
KIRTC#protein kinase C (EC 2.7.1.-) alpha - rat |
| SARAI_0186 |
2003/09/23 |
20%
(345-581) | 3e-34 | 1ERK |
*1 |
KIRTC#protein kinase C (EC 2.7.1.-) alpha - rat |
| SARAI_0187 |
2003/09/23 |
25%
(340-580) | 9e-26 | 3LCK |
*1 |
KIRTC#protein kinase C (EC 2.7.1.-) alpha - rat |
| SARAI_0188 |
2003/09/23 |
21%
(334-580) | 2e-23 | 1IRK |
*1 |
KIRTC#protein kinase C (EC 2.7.1.-) alpha - rat |
| SARAI_0189 |
2003/09/23 |
62%
(102-151) | 3e-23 | 1PTR |
*1 |
KIRTC#protein kinase C (EC 2.7.1.-) alpha - rat |
| SARAI_0190 |
2003/09/23 |
62%
(102-151) | 3e-23 | 1PTR |
*1 |
KIRTC#protein kinase C (EC 2.7.1.-) alpha - rat with ligand |
| SARAI_0191 |
2003/09/23 |
42%
(37-86) | 6e-16 | 1PTR |
*1 |
KIRTC#protein kinase C (EC 2.7.1.-) alpha - rat |
| SARAI_0192 |
2003/09/23 |
42%
(37-86) | 6e-16 | 1PTR |
*1 |
KIRTC#protein kinase C (EC 2.7.1.-) alpha - rat with ligand |
| SARAI_0193 |
2003/09/23 |
28%
(351-616) | 2e-65 | 1A06 |
*1 |
KIRTGC#protein kinase C (EC 2.7.1.-) gamma - rat |
| SARAI_0194 |
2003/09/23 |
66%
(156-288) | 5e-57 | 1A25_B |
*1 |
KIRTGC#protein kinase C (EC 2.7.1.-) gamma - rat |
| SARAI_0195 |
2003/09/23 |
66%
(156-288) | 5e-57 | 1A25_B |
*1 |
KIRTGC#protein kinase C (EC 2.7.1.-) gamma - rat with ligand |
| SARAI_0196 |
2003/09/23 |
66%
(156-288) | 5e-57 | 1A25_A |
*1 |
KIRTGC#protein kinase C (EC 2.7.1.-) gamma - rat |
| SARAI_0197 |
2003/09/23 |
22%
(348-617) | 2e-45 | 1B39_A |
*1 |
KIRTGC#protein kinase C (EC 2.7.1.-) gamma - rat |
| SARAI_0198 |
2003/09/23 |
22%
(348-617) | 2e-45 | 1B39_A |
*1 |
KIRTGC#protein kinase C (EC 2.7.1.-) gamma - rat with ligand |
| SARAI_0199 |
2003/09/23 |
22%
(357-598) | 2e-33 | 1ERK |
*1 |
KIRTGC#protein kinase C (EC 2.7.1.-) gamma - rat |
| SARAI_0200 |
2003/09/23 |
22%
(351-615) | 3e-33 | 1WFC |
*1 |
KIRTGC#protein kinase C (EC 2.7.1.-) gamma - rat |
| SARAI_0201 |
2003/09/23 |
25%
(352-597) | 8e-25 | 3LCK |
*1 |
KIRTGC#protein kinase C (EC 2.7.1.-) gamma - rat |
| SARAI_0202 |
2003/09/23 |
22%
(346-597) | 3e-24 | 1IRK |
*1 |
KIRTGC#protein kinase C (EC 2.7.1.-) gamma - rat |
| SARAI_0203 |
2003/09/23 |
62%
(101-150) | 2e-23 | 1PTR |
*1 |
KIRTGC#protein kinase C (EC 2.7.1.-) gamma - rat |
| SARAI_0204 |
2003/09/23 |
62%
(101-150) | 2e-23 | 1PTR |
*1 |
KIRTGC#protein kinase C (EC 2.7.1.-) gamma - rat with ligand |
| SARAI_0205 |
2003/09/23 |
44%
(36-85) | 2e-16 | 1PTR |
*1 |
KIRTGC#protein kinase C (EC 2.7.1.-) gamma - rat |
| SARAI_0206 |
2003/09/23 |
44%
(36-85) | 2e-16 | 1PTR |
*1 |
KIRTGC#protein kinase C (EC 2.7.1.-) gamma - rat with ligand |
| SARAI_0207 |
2003/09/23 |
67%
(25-542) | 0.0 | 1PKM |
*1 |
KIRTPL#pyruvate kinase (EC 2.7.1.40), hepatic splice form L - rat |
| SARAI_0208 |
2003/09/23 |
18%
(23-212) | 2e-05 | 1KI8_B |
*1 |
P48769#(P48769) Deoxycytidine kinase (EC 2.7.1.74) (dCK) |
| SARAI_0209 |
2003/09/23 |
18%
(23-212) | 2e-05 | 1KI8_B |
*1 |
P48769#(P48769) Deoxycytidine kinase (EC 2.7.1.74) (dCK) with ligand |
| SARAI_0210 |
2003/09/23 |
18%
(23-212) | 5e-05 | 1KI8_A |
*1 |
P48769#(P48769) Deoxycytidine kinase (EC 2.7.1.74) (dCK) |
| SARAI_0211 |
2003/09/23 |
18%
(23-212) | 5e-05 | 1KI8_A |
*1 |
P48769#(P48769) Deoxycytidine kinase (EC 2.7.1.74) (dCK) with ligand |
| SARAI_0212 |
2003/09/23 |
30%
(171-193) | 9e-04 | 3ADK |
*1 |
P48769#(P48769) Deoxycytidine kinase (EC 2.7.1.74) (dCK) |
| SARAI_0213 |
2003/09/23 |
33%
(734-956) | 3e-85 | 3LCK |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0214 |
2003/09/23 |
33%
(764-974) | 7e-79 | 1IRK |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0215 |
2003/09/23 |
31%
(584-705) | 8e-44 | 1IRK |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0216 |
2003/09/23 |
38%
(579-687) | 4e-36 | 3LCK |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0217 |
2003/09/23 |
32%
(768-890) | 5e-18 | 1ERK |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0218 |
2003/09/23 |
26%
(775-943) | 2e-15 | 1B39_A |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0219 |
2003/09/23 |
26%
(775-943) | 2e-15 | 1B39_A |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human with ligand |
| SARAI_0220 |
2003/09/23 |
21%
(591-685) | 1e-12 | 1B39_A |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0221 |
2003/09/23 |
21%
(591-685) | 1e-12 | 1B39_A |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human with ligand |
| SARAI_0222 |
2003/09/23 |
26%
(759-898) | 1e-12 | 1WFC |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0223 |
2003/09/23 |
20%
(736-940) | 8e-12 | 1A06 |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0224 |
2003/09/23 |
22%
(316-413) | 7e-11 | 1TLK |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0225 |
2003/09/23 |
22%
(598-756) | 3e-10 | 1A06 |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0226 |
2003/09/23 |
26%
(586-684) | 6e-08 | 1WFC |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0227 |
2003/09/23 |
22%
(599-687) | 5e-06 | 1ERK |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0228 |
2003/09/23 |
20%
(433-521) | 8e-06 | 1TLK |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0229 |
2003/09/23 |
14%
(227-308) | 7e-04 | 1TLK |
*1 |
PFHUGA#platelet-derived growth factor receptor alpha precursor - human |
| SARAI_0230 |
2003/09/23 |
34%
(777-977) | 3e-78 | 1IRK |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human |
| SARAI_0231 |
2003/09/23 |
41%
(798-965) | 9e-74 | 3LCK |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human |
| SARAI_0232 |
2003/09/23 |
21%
(591-822) | 3e-43 | 1IRK |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human |
| SARAI_0233 |
2003/09/23 |
27%
(586-771) | 8e-36 | 3LCK |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human |
| SARAI_0234 |
2003/09/23 |
36%
(798-898) | 1e-17 | 1ERK |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human |
| SARAI_0235 |
2003/09/23 |
27%
(805-915) | 1e-13 | 1B39_A |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human |
| SARAI_0236 |
2003/09/23 |
27%
(805-915) | 1e-13 | 1B39_A |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human with ligand |
| SARAI_0237 |
2003/09/23 |
21%
(697-913) | 1e-12 | 1WFC |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human |
| SARAI_0238 |
2003/09/23 |
19%
(598-693) | 2e-12 | 1B39_A |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human |
| SARAI_0239 |
2003/09/23 |
19%
(598-693) | 2e-12 | 1B39_A |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human with ligand |
| SARAI_0240 |
2003/09/23 |
24%
(808-948) | 6e-11 | 1A06 |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human |
| SARAI_0241 |
2003/09/23 |
20%
(312-415) | 3e-09 | 1TLK |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human |
| SARAI_0242 |
2003/09/23 |
25%
(597-689) | 7e-09 | 1A06 |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human |
| SARAI_0243 |
2003/09/23 |
26%
(593-691) | 4e-08 | 1WFC |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human |
| SARAI_0244 |
2003/09/23 |
21%
(606-694) | 4e-06 | 1ERK |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human |
| SARAI_0245 |
2003/09/23 |
18%
(225-311) | 1e-05 | 1TLK |
*1 |
PFHUGB#platelet-derived growth factor receptor beta precursor - human |
| SARAI_0246 |
2003/09/23 |
46%
(18-45) | 0.001 | 3ADK |
*1 |
Q9BZX2#(Q9BZX2) Uridine-cytidine kinase 2 (EC 2.7.1.48) |
| SARAI_0247 |
2003/09/23 |
18%
(4-190) | 1e-07 | 3ADK |
*1 |
S26845#dTMP kinase (EC 2.7.4.9) - human |
| SARAI_0248 |
2003/09/23 |
29%
(406-670) | 1e-68 | 1A06 |
*1 |
S28942#protein kinase C (EC 2.7.1.-) epsilon - human |
| SARAI_0249 |
2003/09/23 |
26%
(405-671) | 7e-50 | 1B39_A |
*1 |
S28942#protein kinase C (EC 2.7.1.-) epsilon - human |
| SARAI_0250 |
2003/09/23 |
26%
(405-671) | 7e-50 | 1B39_A |
*1 |
S28942#protein kinase C (EC 2.7.1.-) epsilon - human with ligand |
| SARAI_0251 |
2003/09/23 |
20%
(405-669) | 1e-36 | 1WFC |
*1 |
S28942#protein kinase C (EC 2.7.1.-) epsilon - human |
| SARAI_0252 |
2003/09/23 |
21%
(394-650) | 1e-34 | 1ERK |
*1 |
S28942#protein kinase C (EC 2.7.1.-) epsilon - human |
| SARAI_0253 |
2003/09/23 |
20%
(403-673) | 1e-26 | 1IRK |
*1 |
S28942#protein kinase C (EC 2.7.1.-) epsilon - human |
| SARAI_0254 |
2003/09/23 |
23%
(409-649) | 3e-24 | 3LCK |
*1 |
S28942#protein kinase C (EC 2.7.1.-) epsilon - human |
| SARAI_0255 |
2003/09/23 |
62%
(243-292) | 2e-23 | 1PTR |
*1 |
S28942#protein kinase C (EC 2.7.1.-) epsilon - human |
| SARAI_0256 |
2003/09/23 |
62%
(243-292) | 2e-23 | 1PTR |
*1 |
S28942#protein kinase C (EC 2.7.1.-) epsilon - human with ligand |
| SARAI_0257 |
2003/09/23 |
37%
(170-220) | 3e-14 | 1PTR |
*1 |
S28942#protein kinase C (EC 2.7.1.-) epsilon - human |
| SARAI_0258 |
2003/09/23 |
37%
(170-220) | 3e-14 | 1PTR |
*1 |
S28942#protein kinase C (EC 2.7.1.-) epsilon - human with ligand |
| SARAI_0259 |
2003/09/23 |
32%
(809-1098) | e-102 | 3LCK |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0260 |
2003/09/23 |
31%
(804-1091) | 1e-97 | 1IRK |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0261 |
2003/09/23 |
23%
(508-781) | 5e-92 | 1IRK |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0262 |
2003/09/23 |
21%
(508-777) | 8e-92 | 3LCK |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0263 |
2003/09/23 |
25%
(365-473) | 6e-33 | 1A07_A |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0264 |
2003/09/23 |
25%
(365-473) | 6e-33 | 1A07_A |
*1 |
S43677#protein tyrosine kinase JAK3 - rat with ligand |
| SARAI_0265 |
2003/09/23 |
24%
(370-473) | 7e-33 | 1SKJ |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0266 |
2003/09/23 |
24%
(370-473) | 7e-33 | 1SKJ |
*1 |
S43677#protein tyrosine kinase JAK3 - rat with ligand |
| SARAI_0267 |
2003/09/23 |
25%
(370-473) | 1e-32 | 1A07_B |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0268 |
2003/09/23 |
25%
(370-473) | 1e-32 | 1A07_B |
*1 |
S43677#protein tyrosine kinase JAK3 - rat with ligand |
| SARAI_0269 |
2003/09/23 |
29%
(816-1018) | 2e-31 | 1B39_A |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0270 |
2003/09/23 |
29%
(816-1018) | 2e-31 | 1B39_A |
*1 |
S43677#protein tyrosine kinase JAK3 - rat with ligand |
| SARAI_0271 |
2003/09/23 |
25%
(824-1059) | 7e-29 | 1ERK |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0272 |
2003/09/23 |
18%
(515-718) | 9e-29 | 1B39_A |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0273 |
2003/09/23 |
18%
(515-718) | 9e-29 | 1B39_A |
*1 |
S43677#protein tyrosine kinase JAK3 - rat with ligand |
| SARAI_0274 |
2003/09/23 |
15%
(523-719) | 2e-23 | 1ERK |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0275 |
2003/09/23 |
24%
(810-1018) | 6e-21 | 1WFC |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0276 |
2003/09/23 |
19%
(820-1081) | 2e-20 | 1A06 |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0277 |
2003/09/23 |
19%
(360-473) | 5e-20 | 2ABL |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0278 |
2003/09/23 |
15%
(514-772) | 3e-19 | 1A06 |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0279 |
2003/09/23 |
13%
(506-824) | 2e-16 | 1WFC |
*1 |
S43677#protein tyrosine kinase JAK3 - rat |
| SARAI_0280 |
2003/09/23 |
31%
(9-267) | 2e-85 | 3LCK |
*1 |
S47244#C-raf protein - zebra fish |
| SARAI_0281 |
2003/09/23 |
26%
(8-284) | 1e-79 | 1IRK |
*1 |
S47244#C-raf protein - zebra fish |
| SARAI_0282 |
2003/09/23 |
19%
(8-265) | 2e-40 | 1B39_A |
*1 |
S47244#C-raf protein - zebra fish |
| SARAI_0283 |
2003/09/23 |
19%
(8-265) | 2e-40 | 1B39_A |
*1 |
S47244#C-raf protein - zebra fish with ligand |
| SARAI_0284 |
2003/09/23 |
21%
(15-283) | 1e-36 | 1ERK |
*1 |
S47244#C-raf protein - zebra fish |
| SARAI_0285 |
2003/09/23 |
21%
(9-291) | 4e-35 | 1A06 |
*1 |
S47244#C-raf protein - zebra fish |
| SARAI_0286 |
2003/09/23 |
22%
(15-221) | 4e-30 | 1WFC |
*1 |
S47244#C-raf protein - zebra fish |
| SARAI_0287 |
2003/09/23 |
32%
(340-607) | 9e-93 | 3LCK |
*1 |
TVHUF6#protein kinase raf-1 (EC 2.7.1.-) - human |
| SARAI_0288 |
2003/09/23 |
27%
(340-622) | 4e-80 | 1IRK |
*1 |
TVHUF6#protein kinase raf-1 (EC 2.7.1.-) - human |
| SARAI_0289 |
2003/09/23 |
19%
(353-613) | 1e-40 | 1B39_A |
*1 |
TVHUF6#protein kinase raf-1 (EC 2.7.1.-) - human |
| SARAI_0290 |
2003/09/23 |
19%
(353-613) | 1e-40 | 1B39_A |
*1 |
TVHUF6#protein kinase raf-1 (EC 2.7.1.-) - human with ligand |
| SARAI_0291 |
2003/09/23 |
22%
(351-605) | 6e-38 | 1A06 |
*1 |
TVHUF6#protein kinase raf-1 (EC 2.7.1.-) - human |
| SARAI_0292 |
2003/09/23 |
25%
(355-562) | 4e-37 | 1ERK |
*1 |
TVHUF6#protein kinase raf-1 (EC 2.7.1.-) - human |
| SARAI_0293 |
2003/09/23 |
22%
(331-557) | 1e-33 | 1WFC |
*1 |
TVHUF6#protein kinase raf-1 (EC 2.7.1.-) - human |
| SARAI_0294 |
2003/09/23 |
32%
(139-184) | 2e-11 | 1PTR |
*1 |
TVHUF6#protein kinase raf-1 (EC 2.7.1.-) - human |
| SARAI_0295 |
2003/09/23 |
32%
(139-184) | 2e-11 | 1PTR |
*1 |
TVHUF6#protein kinase raf-1 (EC 2.7.1.-) - human with ligand |
| SARAI_0296 |
2003/09/23 |
38%
(469-758) | e-119 | 1IRK |
*1 |
TVHUFG#fibroblast growth factor receptor 1 precursor - human |
| SARAI_0297 |
2003/09/23 |
38%
(469-761) | e-106 | 3LCK |
*1 |
TVHUFG#fibroblast growth factor receptor 1 precursor - human |
| SARAI_0298 |
2003/09/23 |
22%
(476-729) | 3e-26 | 1B39_A |
*1 |
TVHUFG#fibroblast growth factor receptor 1 precursor - human |
| SARAI_0299 |
2003/09/23 |
22%
(476-729) | 3e-26 | 1B39_A |
*1 |
TVHUFG#fibroblast growth factor receptor 1 precursor - human with ligand |
| SARAI_0300 |
2003/09/23 |
23%
(484-695) | 8e-23 | 1ERK |
*1 |
TVHUFG#fibroblast growth factor receptor 1 precursor - human |
| SARAI_0301 |
2003/09/23 |
23%
(480-744) | 9e-20 | 1A06 |
*1 |
TVHUFG#fibroblast growth factor receptor 1 precursor - human |
| SARAI_0302 |
2003/09/23 |
25%
(463-713) | 2e-18 | 1WFC |
*1 |
TVHUFG#fibroblast growth factor receptor 1 precursor - human |
| SARAI_0303 |
2003/09/23 |
23%
(146-247) | 8e-12 | 1TLK |
*1 |
TVHUFG#fibroblast growth factor receptor 1 precursor - human |
| SARAI_0304 |
2003/09/23 |
27%
(267-358) | 3e-09 | 1TLK |
*1 |
TVHUFG#fibroblast growth factor receptor 1 precursor - human |
| SARAI_0305 |
2003/09/23 |
16%
(48-118) | 2e-05 | 1TLK |
*1 |
TVHUFG#fibroblast growth factor receptor 1 precursor - human |
| SARAI_0306 |
2003/09/23 |
74%
(233-504) | e-133 | 3LCK |
*1 |
TVHULY#protein-tyrosine kinase (EC 2.7.1.112) lyn, splice form A - human |
| SARAI_0307 |
2003/09/23 |
36%
(237-499) | e-114 | 1IRK |
*1 |
TVHULY#protein-tyrosine kinase (EC 2.7.1.112) lyn, splice form A - human |
| SARAI_0308 |
2003/09/23 |
33%
(62-227) | 5e-50 | 2ABL |
*1 |
TVHULY#protein-tyrosine kinase (EC 2.7.1.112) lyn, splice form A - human |
| SARAI_0309 |
2003/09/23 |
50%
(123-227) | 5e-44 | 1A07_A |
*1 |
TVHULY#protein-tyrosine kinase (EC 2.7.1.112) lyn, splice form A - human |
| SARAI_0310 |
2003/09/23 |
50%
(123-227) | 5e-44 | 1A07_A |
*1 |
TVHULY#protein-tyrosine kinase (EC 2.7.1.112) lyn, splice form A - human with ligand |
| SARAI_0311 |
2003/09/23 |
50%
(124-227) | 2e-43 | 1A07_B |
*1 |
TVHULY#protein-tyrosine kinase (EC 2.7.1.112) lyn, splice form A - human |
| SARAI_0312 |
2003/09/23 |
50%
(124-227) | 2e-43 | 1A07_B |
*1 |
TVHULY#protein-tyrosine kinase (EC 2.7.1.112) lyn, splice form A - human with ligand |
| SARAI_0313 |
2003/09/23 |
52%
(127-228) | 5e-43 | 1SKJ |
*1 |
TVHULY#protein-tyrosine kinase (EC 2.7.1.112) lyn, splice form A - human |
| SARAI_0314 |
2003/09/23 |
52%
(127-228) | 5e-43 | 1SKJ |
*1 |
TVHULY#protein-tyrosine kinase (EC 2.7.1.112) lyn, splice form A - human with ligand |
| SARAI_0315 |
2003/09/23 |
26%
(245-439) | 2e-34 | 1B39_A |
*1 |
TVHULY#protein-tyrosine kinase (EC 2.7.1.112) lyn, splice form A - human |
| SARAI_0316 |
2003/09/23 |
26%
(245-439) | 2e-34 | 1B39_A |
*1 |
TVHULY#protein-tyrosine kinase (EC 2.7.1.112) lyn, splice form A - human with ligand |
| SARAI_0317 |
2003/09/23 |
27%
(253-456) | 2e-30 | 1ERK |
*1 |
TVHULY#protein-tyrosine kinase (EC 2.7.1.112) lyn, splice form A - human |
| SARAI_0318 |
2003/09/23 |
20%
(249-487) | 3e-25 | 1A06 |
*1 |
TVHULY#protein-tyrosine kinase (EC 2.7.1.112) lyn, splice form A - human |
| SARAI_0319 |
2003/09/23 |
27%
(240-456) | 3e-25 | 1WFC |
*1 |
TVHULY#protein-tyrosine kinase (EC 2.7.1.112) lyn, splice form A - human |